Ensacove

Active Ingredient(s): Ensartinib Hydrochloride
FDA Approved: * December 18, 2024
Pharm Company: * XCOVERY
Category: Cancer
* May have multiple approval dates, manufacturers, or labelers.

Dosage List

Ensacove 25 mg Oral Capsule
NDC: 83076-1025
Labeler:
Xcovery Holdings, Inc.
Ensacove 100 mg Oral Capsule
NDC: 83076-1100
Labeler:
Xcovery Holdings, Inc.